Growth Opportunities C-RAD operates in SGRT for radiotherapy, a specialized niche with growing patient safety and efficiency mandates. Potential sales opportunities include expanding to clinics seeking safer positioning, motion management, and respiratory tracking solutions, especially in markets with rising cancer treatment demand.

Strategic Partnerships Recent partnerships with Xiel Ltd in the UK/Ireland, Innokas Medical in Sweden, and PSG Hospitals in India indicate a market-tailored collaborative approach. Leverage these relationships to approach similar regional distributors, system integrators, and hospital networks to accelerate adoption of Catalyst+HD and Sentinel 4DCT.

Product Adoption Launch of Catalyst+HD and Sentinel 4DCT signals a push into advanced SGRT capabilities. Target mid- to large-format radiotherapy centers seeking workflow optimization and precision gains, emphasizing faster onboarding, compatibility with existing imaging suites, and demonstrated treatment accuracy improvements.

Leadership and Focus New leadership and CFO appointments suggest a phase of scaling and financial discipline. Propose executive briefings with C-RAD to discuss regional expansion plans, ROI case studies, and long-term service agreements to support growth in international markets.

Market Position Operating with a lean employee base in a high-value medical equipment segment, C-RAD presents opportunities to target smaller regional hospitals and oncology centers alongside larger players. Offer modular or upgradeable SGRT components and flexible financing to address diverse customer sizes and budgets.